litlas
ログインアカウント作成

Michael R. Verneris

2001–2025 年に発表

96
論文数
19,151
被引用数
64
h 指数
91
i10 指数

被引用数

Michael R. Verneris の年別被引用数1994 年: 被引用 2 件2001 年: 被引用 2 件2002 年: 被引用 12 件2003 年: 被引用 18 件2004 年: 被引用 11 件2005 年: 被引用 23 件2006 年: 被引用 18 件2007 年: 被引用 34 件2008 年: 被引用 41 件2009 年: 被引用 56 件2010 年: 被引用 65 件2011 年: 被引用 80 件2012 年: 被引用 61 件2013 年: 被引用 104 件2014 年: 被引用 133 件2015 年: 被引用 148 件2016 年: 被引用 160 件2017 年: 被引用 182 件2018 年: 被引用 280 件2019 年: 被引用 945 件2020 年: 被引用 1,080 件2021 年: 被引用 1,123 件2022 年: 被引用 957 件2023 年: 被引用 724 件2024 年: 被引用 1,101 件2025 年: 被引用 549 件2026 年: 被引用 14 件1995〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,180 件、この内訳の 32.2%中国: 引用元論文 987 件、この内訳の 10%ドイツ: 引用元論文 722 件、この内訳の 7.3%イギリス: 引用元論文 500 件、この内訳の 5.1%イタリア: 引用元論文 467 件、この内訳の 4.7%フランス: 引用元論文 420 件、この内訳の 4.2%スペイン: 引用元論文 326 件、この内訳の 3.3%カナダ: 引用元論文 284 件、この内訳の 2.9%オランダ: 引用元論文 256 件、この内訳の 2.6%オーストラリア: 引用元論文 237 件、この内訳の 2.4%日本: 引用元論文 227 件、この内訳の 2.3%スイス: 引用元論文 194 件、この内訳の 2%
0%32.2%その他 21%

機関

分野

  • Medicine67.1%
  • Immunology and Microbiology25.7%
  • Biochemistry, Genetics and Molecular Biology6%
  • Engineering0.5%
  • Neuroscience0.2%
  • Agricultural and Biological Sciences0.1%
  • その他0.4%

トピック

  • CAR-T cell therapy research19.9%
  • Immune Cell Function and Interaction12.3%
  • T-cell and B-cell Immunology5.2%
  • Virus-based gene therapy research4.8%
  • Hematopoietic Stem Cell Transplantation4.7%
  • Immunotherapy and Immune Responses3.5%
  • その他49.6%

共著者

全論文

検索で開く
  1. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    著者: Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R. Verneris, Heather E. Stefanski, Gary D. Myers, Muna Qayed, Barbara De Moerloose, Hidefumi Hiramatsu, Krysta Schlis, Kara L. Davis, Paul L. Martin, Eneida R. Nemecek, Gregory A. Yanik, Christina Peters, André Baruchel, Nicolas Boissel, Françoise Méchinaud, Adriana Balduzzi, Joerg Krueger, Carl H. June, Bruce L. Levine, Patricia A. Wood, Tetiana Taran, Mimi Leung, Karen T. Mueller, Yiyun Zhang, Kapildeb Sen, David Lebwohl, Michael A. Pulsipher, Stephan A. Grupp - New England Journal of Medicine 2018 被引用: 5,641

  2. Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

    著者: Elena J. Orlando, Xia Han, Catherine Tribouley, Patricia A. Wood, Rebecca Leary, Markus Riester, John E. Levine, Muna Qayed, Stephan A. Grupp, Michael Boyer, Barbara De Moerloose, Eneida R. Nemecek, Henrique Bittencourt, Hidefumi Hiramatsu, Jochen Buechner, Stella M. Davies, Michael R. Verneris, Kevin T. Nguyen, Jennifer L. Brogdon, Hans Bitter, Michael Morrissey, Piotr Pierog, Serafino Pantano, Jeffrey A. Engelman, Wendy Winckler - Nature Medicine 2018 被引用: 567

  3. Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

    著者: R. Coleman Lindsley, Wael Saber, Brenton G. Mar, Robert Redd, Tao Wang, Michael Haagenson, Peter Grauman, Zhen‐Huan Hu, Stephen R. Spellman, Stephanie J. Lee, Michael R. Verneris, Katharine C. Hsu, Katharina Fleischhauer, Corey Cutler, Joseph H. Antin, Donna Neuberg, Benjamin L. Ebert - New England Journal of Medicine 2017 被引用: 770

  4. Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report

    著者: Liora M. Schultz, Christina Baggott, Snehit Prabhu, Holly L. Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Steven P. Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole A. Karras, Patrick A. Brown, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Rayne H. Rouce, Vasant Chinnabhandar, Michael Kunicki, Valentin V. Barsan, A. Yasemin Goksenin, Yimei Li, Sharon Mavroukakis, Emily Egeler, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch - Journal of Clinical Oncology 2021 被引用: 201

  5. First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

    著者: Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott, Peter Westervelt, Michael R. Verneris, John E. Wagner, Daniel J. Weisdorf, Bruce R. Blazar, Celalettin Üstün, Todd E. DeFor, Sithara Vivek, Lindsey Peck, John F. DiPersio, Amanda F. Cashen, Rachel L. Kyllo, Amy Musiek, András Schaffer, Milan J. Anadkat, Ilana S. Rosman, Daniel D. Miller, Jack O. Egan, Emily K. Jeng, Amy D. Rock, Hing C. Wong, Todd A. Fehniger, Jeffrey S. Miller - Blood 2018 被引用: 407

  6. IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

    著者: Daniel A. Vallera, Martin Felices, Ron McElmurry, Valarie McCullar, Xianzheng Zhou, Joerg Uwe Schmohl, Bin Zhang, Alexander J. Lenvik, Angela Panoskaltsis‐Mortari, Michael R. Verneris, Jakub Tolar, Sarah Cooley, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller - Clinical Cancer Research 2016 被引用: 368

  7. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein

    著者: Veronika Bachanová, Sarah Cooley, Todd E. DeFor, Michael R. Verneris, Bin Zhang, David H. McKenna, Julie Curtsinger, Angela Panoskaltsis‐Mortari, Dixie Lewis, Keli L. Hippen, Philip B. McGlave, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller - Blood 2014 被引用: 432

  8. Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

    著者: Adam J. Lamble, Regina M. Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M. Steinberg, Jennifer Sheppard, Alexandra E. Kovach, Brent L. Wood, Michael J. Borowitz, Maryalice Stetler‐Stevenson, Constance M. Yuan, Vinodh Pillai, Toni Foley, Perry Chung, Lee Chen, Daniel W. Lee, Colleen Annesley, Amanda M. DiNofia, Stephan A. Grupp, Michael R. Verneris, Lia Gore, Theodore W. Laetsch, Deepa Bhojwani, Patrick A. Brown, Michael A. Pulsipher, Susan R. Rheingold, Rebecca Gardner, Nirali N. Shah - Blood Advances 2022 被引用: 140

  9. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

    著者: Michelle Gleason, Todd Lenvik, Valarie McCullar, Martin Felices, MM O'Brien, Sarah A. Cooley, Michael R. Verneris, Frank Cichocki, Carol Holman, Angela Panoskaltsis‐Mortari, Toshiro Niki, Mitsuomi Hirashima, Bruce R. Blazar, Jeffrey S. Miller - Blood 2012 被引用: 372

  10. Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most

    著者: Bronwen E. Shaw, Brent R. Logan, Stephen R. Spellman, Steven G. E. Marsh, James Robinson, Joseph Pidala, Carolyn Katovich Hurley, Juliet N. Barker, Martin Maiers, Jason Dehn, Hailin Wang, Mike Haagenson, David Porter, Effie W. Petersdorf, Ann E. Woolfrey, Mary M. Horowitz, Michael R. Verneris, Katharine C. Hsu, Katharina Fleischhauer, Stephanie J. Lee - Biology of Blood and Marrow Transplantation 2018 被引用: 167

  11. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

    著者: Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie‐An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz, Kevin J. Curran - Blood Advances 2021 被引用: 111

  12. Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

    著者: Claudio G. Brunstein, Jeffrey S. Miller, David H. McKenna, Keli L. Hippen, Todd E. DeFor, Darin Sumstad, Julie Curtsinger, Michael R. Verneris, Margaret L. MacMillan, Bruce L. Levine, James L. Riley, Carl H. June, Chap T. Le, Daniel J. Weisdorf, Philip B. McGlave, Bruce R. Blazar, John E. Wagner - Blood 2015 被引用: 401

  13. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

    著者: Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori, Rebecca Marsh, Lauri M. Burroughs, Navneet S. Majhail, A. Samer Al‐Homsi, Zaid Al‐Kadhimi, Merav Bar, Alice Bertaina, Jaap Jan Boelens, Richard E. Champlin, Sonali Chaudhury, Zachariah DeFilipp, Bhagirathbhai Dholaria, Areej El‐Jawahri, Suzanne Fanning, Ellen Fraint, Usama Gergis, Sergio Giralt, Betty K. Hamilton, Shahrukh K. Hashmi, Biljana Horn, Yoshihiro Inamoto, David A. Jacobsohn, Tania Jain, Laura Johnston, Abraham S. Kanate, Ankit Kansagra, Adetola A. Kassim, Leslie S. Kean, Carrie L. Kitko, Jessica Knight‐Perry, Joanne Kurtzberg, Hien Liu, Margaret L. MacMillan, Zahra Mahmoudjafari, Marco Mielcarek, Mohamad Mohty, Arnon Nagler, Eneida R. Nemecek, Timothy S. Olson, Betül Oran, Miguel‐Angel Perales, Susan E. Prockop, Michael A. Pulsipher, Iskra Pusic, Marcie Riches, Cesar Rodriguez, Rizwan Romee, Gabriela Rondón, Ayman Saad, Nina Shah, Peter J. Shaw, Shalini Shenoy, Jorge Sierra, Julie‐An Talano, Michael R. Verneris, Paul Veys, John E. Wagner, Bipin N. Savani, Mehdi Hamadani, Paul A. Carpenter - Transplantation and Cellular Therapy 2021 被引用: 181

  14. Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia

    著者: Gary D. Myers, Michael R. Verneris, André Goy, Richard T. Maziarz - Journal for ImmunoTherapy of Cancer 2021 被引用: 97

  15. CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial

    著者: Nirali N. Shah, Sarah K. Tasian, M. Eric Kohler, Emily M. Hsieh, Susanne H.C. Baumeister, Corinne Summers, Haneen Shalabi, Jessica A. Pollard, Bonnie Yates, Ruta Brazauskas, Eric Ndifon, Constance M. Yuan, Hao‐Wei Wang, Hati Kobusingye, Kayla Christianson, Allison A Weiss, Erin Leckrone, Bronwen E. Shaw, Jeffery J. Auletta, Hemalatha G. Rangarajan, John Roach, Julie Blake, Dennis F. Michiel, Brian Bowser, Sheryl Ruppel, George Mitra, Anthony Welch, Jason L. Yovandich, Rachelle Salomon, Leslie S. Kean, Katherine Tarlock, Michael A. Pulsipher, Michael R. Verneris, Larisa Broglie, Terry J. Fry, Steven M. Devine, Richard Aplenc - Blood 2023 被引用: 57

  16. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity

    著者: Petter Woll, Bartosz Grzywacz, Xinghui Tian, Rebecca Marcus, David A. Knorr, Michael R. Verneris, Dan S. Kaufman - Blood 2009 被引用: 268

  17. Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen

    著者: Bree Foley, Sarah Cooley, Michael R. Verneris, Julie Curtsinger, Xianghua Luo, Edmund K. Waller, Claudio Anasetti, Daniel J. Weisdorf, Jeffrey S. Miller - The Journal of Immunology 2012 被引用: 358

  18. Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells

    著者: Dhifaf Sarhan, Frank Cichocki, Bin Zhang, Ashley Yingst, Stephen R. Spellman, Sarah Cooley, Michael R. Verneris, Bruce R. Blazar, Jeffrey S. Miller - Cancer Research 2016 被引用: 201

  19. Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

    著者: Heather E. Stefanski, Anne Eaton, Christina Baggott, Jenna Rossoff, Michael R. Verneris, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Julie-An Talano, Amy Moskop, Steven Margossian, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, M. Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz - Blood Advances 2022 被引用: 51

  20. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

    著者: Bree Foley, Sarah Cooley, Michael R. Verneris, Michelle Pitt, Julie Curtsinger, Xianghua Luo, Sandra López‐Vergès, Lewis L. Lanier, Daniel J. Weisdorf, Jeffrey S. Miller - Blood 2011 被引用: 612

  21. CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets

    著者: Michelle Gleason, Julie A. Ross, Erica D. Warlick, Troy C. Lund, Michael R. Verneris, Andres Wiernik, Stephen R. Spellman, Michael Haagenson, Alexander J. Lenvik, Mark R. Litzow, Pearlie K. Epling‐Burnette, Bruce R. Blazar, Louis M. Weiner, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller - Blood 2014 被引用: 258

  22. Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

    著者: Amy Moskop, Lauren Pommert, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Steve P. Margossian, Michael R. Verneris, Gary D. Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Erin Guest, Erin H. Breese, Liora M. Schultz - Blood Advances 2022 被引用: 64

  23. Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia

    著者: John E. Levine, Stephan A. Grupp, Michael A. Pulsipher, Andrew C. Dietz, Susana Rives, Gary Douglas Myers, Keith J. August, Michael R. Verneris, Jochen Buechner, Theodore W. Laetsch, Henrique Bittencourt, André Baruchel, Michael W. Boyer, Barbara De Moerloose, Muna Qayed, Stella M. Davies, Christine L. Phillips, Timothy A. Driscoll, Peter Bader, Krysta Schlis, Patricia A. Wood, Rajen Mody, Lan Yi, Mimi Leung, Lamis Eldjerou, Carl H. June, Shannon L. Maude - Journal for ImmunoTherapy of Cancer 2021 被引用: 64

  24. Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

    著者: Vanessa A. Fabrizio, Christine L. Phillips, Adam Lane, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Jenna Rossoff, Heather E. Stefanski, Julie‐An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz - Blood Advances 2021 被引用: 81